Sergio Giralt Selected Research

alpha-isobutyl-4-hydroxybenzyl alcohol (T 108)

9/2011

Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergio Giralt Research Topics

Disease

59	Multiple Myeloma 10/2022 - 09/2003
38	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2002
37	Neoplasms (Cancer) 01/2022 - 01/2002
32	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 08/2004
30	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2002
26	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 01/2002
15	Leukemia 01/2022 - 01/2002
12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2015 - 01/2000
11	Lymphoma (Lymphomas) 01/2021 - 06/2004
10	Infections 12/2021 - 02/2009
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2002
10	Disease Progression 01/2019 - 06/2004
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 06/2004
7	Bronchiolitis Obliterans Syndrome 01/2022 - 03/2004
5	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 02/2010
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 05/2003
4	Cytokine Release Syndrome 01/2021 - 02/2014
4	Pain (Aches) 01/2020 - 04/2007
4	Neutropenia 01/2020 - 10/2011
3	Plasma Cell Leukemia 07/2022 - 10/2006
3	Residual Neoplasm 01/2021 - 09/2010
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2006 - 01/2004
2	Cytopenia 11/2021 - 11/2020
2	cell-associated neurotoxicity 01/2021 - 01/2020
2	Pathologic Complete Response 11/2020 - 08/2004
2	Viremia 10/2020 - 10/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2016 - 06/2008
2	Frailty 10/2014 - 04/2007
2	Philadelphia Chromosome 02/2014 - 04/2012
2	Blast Crisis (Blast Phase) 03/2011 - 08/2006
2	Renal Insufficiency (Renal Failure) 11/2010 - 08/2005
2	Hemorrhagic Cystitis 07/2010 - 06/2004
2	Myeloid Leukemia (Leukemia, Myelocytic) 08/2009 - 02/2005
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2003 - 04/2003

Drug/Important Bio-Agent (IBA)

20	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 05/2003
12	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 03/2003
11	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 05/2003
10	Lenalidomide (CC 5013)FDA Link 01/2022 - 10/2007
10	Rituximab (Mabthera)FDA Link 01/2020 - 04/2003
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2003
9	fludarabineIBA 01/2020 - 08/2004
6	trans-crotonin (CTN)IBA 10/2022 - 12/2011
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 06/2011
6	Chimeric Antigen ReceptorsIBA 01/2022 - 02/2014
6	Busulfan (Busulfex)FDA Link 01/2020 - 03/2003
6	Tyrosine Kinase InhibitorsIBA 04/2012 - 03/2007
6	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 01/2000
5	Bortezomib (Velcade)FDA Link 01/2022 - 04/2007
5	Alemtuzumab (Campath)FDA Link 12/2014 - 05/2003
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 01/2002
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2014 - 08/2005
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014 - 04/2003
4	SteroidsIBA 12/2009 - 06/2004
3	ixazomibIBA 07/2022 - 01/2020
3	Calcineurin InhibitorsIBA 01/2022 - 11/2012
3	CytokinesIBA 11/2021 - 06/2009
3	axicabtagene ciloleucelIBA 01/2021 - 01/2020
3	tisagenlecleucelIBA 01/2021 - 01/2020
3	Azacitidine (5 Azacytidine)FDA Link 11/2020 - 05/2009
3	Etoposide (VP 16)FDA LinkGeneric 10/2015 - 05/2003
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2015 - 05/2013
3	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2014 - 01/2002
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 06/2013 - 06/2004
3	HLA Antigens (Human Leukocyte Antigens)IBA 03/2013 - 03/2007
3	Pharmaceutical PreparationsIBA 05/2012 - 04/2007
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2011 - 06/2004
3	Phosphotransferases (Kinase)IBA 03/2011 - 08/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2003
2	FluoroquinolonesIBA 12/2021 - 10/2014
2	Proteasome InhibitorsIBA 11/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 07/2006
2	Decitabine FDA Link 01/2021 - 03/2003
2	Ferritins (Ferritin)IBA 11/2020 - 01/2009
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2018
2	Surface Antigens (Surface Antigen)IBA 11/2019 - 05/2010
2	defibrotideIBA 03/2016 - 08/2012
2	VaccinesIBA 12/2015 - 08/2010
2	Ifosfamide FDA LinkGeneric 10/2015 - 06/2011
2	Sirolimus (Rapamycin)FDA Link 03/2015 - 03/2014
2	Biological ProductsIBA 12/2011 - 11/2008
2	Thalidomide (Thalomid)FDA Link 02/2010 - 08/2009
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	venetoclaxIBA 12/2021
1	Transaminases (Aminotransferases)IBA 11/2021

Therapy/Procedure

62	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2003
47	Therapeutics 07/2022 - 01/2003
47	Transplantation 01/2022 - 01/2002
45	Stem Cell Transplantation 01/2022 - 01/2002
30	Cell Transplantation 07/2022 - 12/2007
22	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
15	Homologous Transplantation 07/2022 - 01/2002
6	Autologous Transplantation 01/2019 - 06/2004
6	Hematopoietic Stem Cell Mobilization 01/2017 - 07/2006
5	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2011 - 01/2002
4	Salvage Therapy 12/2021 - 06/2004
3	Radiotherapy 01/2020 - 05/2007
3	Immunotherapy 01/2020 - 08/2010
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2005 - 01/2002
2	Induction Chemotherapy 04/2014 - 04/2010